⌘K
| Date | TitleTitle | |||
|---|---|---|---|---|
| 06/07/22 | 07:00:11 | 6 Jul 2022 | Grant of Options | |
| 30/06/22 | 13:45:04 | 30 Jun 2022 | Result of AGM | |
| 23/06/22 | 16:40:51 | 23 Jun 2022 | Second Price Monitoring Extn | |
| 23/06/22 | 16:35:52 | 23 Jun 2022 | Price Monitoring Extension | |
| 15/06/22 | 14:30:40 | 15 Jun 2022 | Holding(s) in Company | |
| 09/06/22 | 15:00:01 | 9 Jun 2022 | Exercise of Options and Total Voting Rights | |
| 06/06/22 | 16:25:53 | 6 Jun 2022 | Posting of Annual Report & Notice of AGM | |
| 25/05/22 | 07:00:08 | 25 May 2022 | Full Year Results | |
| 18/05/22 | 16:36:05 | 18 May 2022 | Price Monitoring Extension | |
| 16/05/22 | 07:00:06 | 16 May 2022 | Synairgen presents at ATS 2022 | |
| 25/04/22 | 07:00:08 | 25 Apr 2022 | Presentation at ECCMID | |
| 19/04/22 | 16:40:36 | 19 Apr 2022 | Second Price Monitoring Extn | |
| 19/04/22 | 16:35:59 | 19 Apr 2022 | Price Monitoring Extension | |
| 06/04/22 | 14:10:01 | 6 Apr 2022 | Holding(s) in Company | |
| 05/04/22 | 07:00:06 | 5 Apr 2022 | Synairgen to present at ATS 2022 | |
| 17/03/22 | 07:25:03 | 17 Mar 2022 | Synairgen Provides Update on ACTIV-2 Trial | |
| 14/03/22 | 16:41:28 | 14 Mar 2022 | Second Price Monitoring Extn | |
| 14/03/22 | 16:36:42 | 14 Mar 2022 | Price Monitoring Extension | |
| 11/03/22 | 16:40:30 | 11 Mar 2022 | Second Price Monitoring Extn | |
| 11/03/22 | 16:35:40 | 11 Mar 2022 | Price Monitoring Extension | |
| 08/03/22 | 16:35:06 | 8 Mar 2022 | Holding(s) in Company | |
| 08/03/22 | 15:52:40 | 8 Mar 2022 | Holding(s) in Company | |
| 04/03/22 | 13:36:57 | 4 Mar 2022 | Holding(s) in Company | |
| 03/03/22 | 07:00:05 | 3 Mar 2022 | Update on SNG001 | |
| 24/02/22 | 11:30:06 | 24 Feb 2022 | Holding(s) in Company | |
| 23/02/22 | 11:25:05 | 23 Feb 2022 | Holding(s) in Company | |
| 21/02/22 | 07:00:08 | 21 Feb 2022 | Topline results from Phase 3 SPRINTER trial | |
| 04/02/22 | 16:54:03 | 4 Feb 2022 | Holding(s) in Company | |
| 28/01/22 | 07:00:09 | 28 Jan 2022 | Director/PDMR Shareholding | |
| 19/01/22 | 14:05:09 | 19 Jan 2022 | Holding(s) in Company | |
| 12/01/22 | 11:53:46 | 12 Jan 2022 | Holding(s) in Company | |
| 07/01/22 | 17:25:01 | 7 Jan 2022 | Holding(s) in Company | |
| 06/01/22 | 12:00:05 | 6 Jan 2022 | Synairgen announces partnership with Ashfield | |
| 23/12/21 | 16:15:01 | 23 Dec 2021 | Holding(s) in Company | |
| 23/12/21 | 14:19:53 | 23 Dec 2021 | Holding(s) in Company | |
| 21/12/21 | 17:05:08 | 21 Dec 2021 | Holding(s) in Company | |
| 08/12/21 | 07:00:07 | 8 Dec 2021 | Data Presented at ESWI Influenza Conference | |
| 06/12/21 | 17:30:01 | 6 Dec 2021 | Holding(s) in Company | |
| 06/12/21 | 07:00:09 | 6 Dec 2021 | Synairgen Presents SNG001 Data at ESWI | |
| 19/11/21 | 14:26:42 | 19 Nov 2021 | Holding(s) in Company | |
| 11/11/21 | 07:00:03 | 11 Nov 2021 | Synairgen completes Phase III recruitment | |
| 08/11/21 | 12:58:18 | 8 Nov 2021 | Holding(s) in Company | |
| 26/10/21 | 15:13:21 | 26 Oct 2021 | Holding(s) in Company | |
| 21/10/21 | 17:39:36 | 21 Oct 2021 | Holdings in Company | |
| 21/10/21 | 07:00:04 | 21 Oct 2021 | Grant of Options | |
| 20/10/21 | 07:00:06 | 20 Oct 2021 | SNG001 progresses to Phase 3 of ACTIV-2 trial | |
| 13/10/21 | 07:00:09 | 13 Oct 2021 | Synairgen appoints Gareth Walters, Ph.D. as CRO | |
| 05/10/21 | 11:25:07 | 5 Oct 2021 | Holding(s) in Company | |
| 30/09/21 | 07:02:07 | 30 Sept 2021 | Non-Executive Director Appointment | |
| 30/09/21 | 07:00:12 | 30 Sept 2021 | Interim results |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 06/07/22 | 07:00:11 | 6 Jul 2022 | Grant of Options | |
| 30/06/22 | 13:45:04 | 30 Jun 2022 | Result of AGM | |
| 23/06/22 | 16:40:51 | 23 Jun 2022 | Second Price Monitoring Extn | |
| 23/06/22 | 16:35:52 | 23 Jun 2022 | Price Monitoring Extension | |
| 15/06/22 | 14:30:40 | 15 Jun 2022 | Holding(s) in Company | |
| 09/06/22 | 15:00:01 | 9 Jun 2022 | Exercise of Options and Total Voting Rights | |
| 06/06/22 | 16:25:53 | 6 Jun 2022 | Posting of Annual Report & Notice of AGM | |
| 25/05/22 | 07:00:08 | 25 May 2022 | Full Year Results | |
| 18/05/22 | 16:36:05 | 18 May 2022 | Price Monitoring Extension | |
| 16/05/22 | 07:00:06 | 16 May 2022 | Synairgen presents at ATS 2022 | |
| 25/04/22 | 07:00:08 | 25 Apr 2022 | Presentation at ECCMID | |
| 19/04/22 | 16:40:36 | 19 Apr 2022 | Second Price Monitoring Extn | |
| 19/04/22 | 16:35:59 | 19 Apr 2022 | Price Monitoring Extension | |
| 06/04/22 | 14:10:01 | 6 Apr 2022 | Holding(s) in Company | |
| 05/04/22 | 07:00:06 | 5 Apr 2022 | Synairgen to present at ATS 2022 | |
| 17/03/22 | 07:25:03 | 17 Mar 2022 | Synairgen Provides Update on ACTIV-2 Trial | |
| 14/03/22 | 16:41:28 | 14 Mar 2022 | Second Price Monitoring Extn | |
| 14/03/22 | 16:36:42 | 14 Mar 2022 | Price Monitoring Extension | |
| 11/03/22 | 16:40:30 | 11 Mar 2022 | Second Price Monitoring Extn | |
| 11/03/22 | 16:35:40 | 11 Mar 2022 | Price Monitoring Extension | |
| 08/03/22 | 16:35:06 | 8 Mar 2022 | Holding(s) in Company | |
| 08/03/22 | 15:52:40 | 8 Mar 2022 | Holding(s) in Company | |
| 04/03/22 | 13:36:57 | 4 Mar 2022 | Holding(s) in Company | |
| 03/03/22 | 07:00:05 | 3 Mar 2022 | Update on SNG001 | |
| 24/02/22 | 11:30:06 | 24 Feb 2022 | Holding(s) in Company | |
| 23/02/22 | 11:25:05 | 23 Feb 2022 | Holding(s) in Company | |
| 21/02/22 | 07:00:08 | 21 Feb 2022 | Topline results from Phase 3 SPRINTER trial | |
| 04/02/22 | 16:54:03 | 4 Feb 2022 | Holding(s) in Company | |
| 28/01/22 | 07:00:09 | 28 Jan 2022 | Director/PDMR Shareholding | |
| 19/01/22 | 14:05:09 | 19 Jan 2022 | Holding(s) in Company | |
| 12/01/22 | 11:53:46 | 12 Jan 2022 | Holding(s) in Company | |
| 07/01/22 | 17:25:01 | 7 Jan 2022 | Holding(s) in Company | |
| 06/01/22 | 12:00:05 | 6 Jan 2022 | Synairgen announces partnership with Ashfield | |
| 23/12/21 | 16:15:01 | 23 Dec 2021 | Holding(s) in Company | |
| 23/12/21 | 14:19:53 | 23 Dec 2021 | Holding(s) in Company | |
| 21/12/21 | 17:05:08 | 21 Dec 2021 | Holding(s) in Company | |
| 08/12/21 | 07:00:07 | 8 Dec 2021 | Data Presented at ESWI Influenza Conference | |
| 06/12/21 | 17:30:01 | 6 Dec 2021 | Holding(s) in Company | |
| 06/12/21 | 07:00:09 | 6 Dec 2021 | Synairgen Presents SNG001 Data at ESWI | |
| 19/11/21 | 14:26:42 | 19 Nov 2021 | Holding(s) in Company | |
| 11/11/21 | 07:00:03 | 11 Nov 2021 | Synairgen completes Phase III recruitment | |
| 08/11/21 | 12:58:18 | 8 Nov 2021 | Holding(s) in Company | |
| 26/10/21 | 15:13:21 | 26 Oct 2021 | Holding(s) in Company | |
| 21/10/21 | 17:39:36 | 21 Oct 2021 | Holdings in Company | |
| 21/10/21 | 07:00:04 | 21 Oct 2021 | Grant of Options | |
| 20/10/21 | 07:00:06 | 20 Oct 2021 | SNG001 progresses to Phase 3 of ACTIV-2 trial | |
| 13/10/21 | 07:00:09 | 13 Oct 2021 | Synairgen appoints Gareth Walters, Ph.D. as CRO | |
| 05/10/21 | 11:25:07 | 5 Oct 2021 | Holding(s) in Company | |
| 30/09/21 | 07:02:07 | 30 Sept 2021 | Non-Executive Director Appointment | |
| 30/09/21 | 07:00:12 | 30 Sept 2021 | Interim results |